Acute effects of various GABA receptor agonists and glutamate antagonists on focal hippocampal seizures in freely moving rats elicited by low-frequency stimulation

Synapse

Volumn 28, Issue 1, 1998, Pages 103-109

  Katsumori, Hiroshi ^a,b   Minabe, Yoshio ^a   Osawa, Makiko ^b   Ashby Jr , Charles R ^c  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^c NONE

Author keywords

Anticonvulsant; Dentate gyrus; GABA; Glutamate; Kindling

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR; 4 PHOSPHONOMETHYLPIPECOLIC ACID; 6 (1 IMIDAZOLYL) 7 NITRO 2,3 QUINOXALINEDIONE; 7 CHLOROKYNURENIC ACID; AMPA RECEPTOR; CARBAMAZEPINE; DIAZEPAM; DIZOCILPINE; GLUTAMATE RECEPTOR ANTAGONIST; GLUTAMIC ACID; MUSCIMOL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; 6-(1H-IMIDAZOL-1-YL)-7-NITRO-2,3(1H,4H)-QUINOXALINEDIONE; 7-CHLOROKYNURENIC ACID; AMINO ACID RECEPTOR BLOCKING AGENT; ANTICONVULSIVE AGENT; DIZOCILPINE MALEATE; DRUG DERIVATIVE; KYNURENIC ACID; PIPECOLIC ACID DERIVATIVE; QUINOXALINE DERIVATIVE;

AFTERDISCHARGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATAXIA; CONTROLLED STUDY; DENTATE GYRUS; DOSE RESPONSE; ELECTROENCEPHALOGRAM; HIPPOCAMPUS; KINDLING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE; SEIZURE THRESHOLD; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; WISTAR RAT;

ANIMALS; ANTICONVULSANTS; ATAXIA; CARBAMAZEPINE; DIAZEPAM; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; GABA AGONISTS; HIPPOCAMPUS; KYNURENIC ACID; MALE; MUSCIMOL; PIPECOLIC ACIDS; QUINOXALINES; RATS; RATS, WISTAR; SEIZURES;

EID: 0008118755     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(199801)28:1<103::AID-SYN12>3.0.CO;2-Y     Document Type: Article

References (39)

1. B receptor antagonists: From synthesis to therapeutic application. Trends Pharmacol. Sci., 14:391-394.
2. Burdette, L.J., and Dyer, R.S. (1987) Differential effects of caffeine, picrotoxin and pentylenetetrazol on hippocampal afterdischarge activity and wet dog shakes. Exp. Neurol., 96:381-392.
3. Croucher, M.J., and Bradford, H.F. (1991) The influence of strychnine-insensitive glycine receptor agonists and antagonists on generalized seizure thresholds. Brain Res., 543:91-96.
4. Croucher, M.J., Cotterell, K.L., and Bradford, H.F. (1992) Competitive NMDA receptor antagonists raise electrically-kindled generalized seizure thresholds. Neurochemical Res., 17:409-413.
5. Dichter, M.A. (1989) Cellular mechanisms of epilepsy and potential new treatment strategies. Epilepsia 30(suppl. 1):S3-S12.
6. Dichter, M.A. (1994) Emerging insights into mechanisms of epilepsy, implications for new antiepileptic drug development. Epilepsia, 35:S51-S57.
7. Eadie, M.J., and Tyrer, J.H. (Eds), Anticonvulsant Therapy: Pharmacological Basis and Practice. 3rd Ed. Churchill Livingstone, London, 1989.
8. Gilbert, M.E. (1994) The NMDA antagonist MK-801 suppresses behavioral seizures, augments afterdischarges, but does not block development of perforant pathway kindling. Epilepsy Res., 17:145-156.
9. Gilbert, M.E., and Mack, C.M. (1990) The NMDA antagonist, MK-801, suppresses long-term potentiation, kindling and kindling-induced potentiation in the perforant path of the unanesthetized rat. Brain Res., 519:89-96.
10. Grace, G.M., Corcoran, M.E., and Skelton, R.W. (1990) Kindling with stimulation of dentate gyrus. I. Characterization of electrographic and behavioral events. Brain Res., 509:249-256.
11. Lee, W.-L., and Hablitz, J.J. (1989) Involvement of non-NMDA receptors in picrotoxin-induced epileptiform activity in the hippocampus. Neurosci. Lett., 107:129-134.
12. Lehman, J., Huchinson, A.J., McPherson, S.E., Mondadori, C., Schmutz, M., Sinton, C.M., Tsai, C., Murphy, D.E., Steel, D.J., Willams, M., Cheney, D.L., and Wood, P.L. (1988) CGS19755, a selective and competitive n-methyl-d-aspartate-type excitatory amino acid receptor antagonist. J. Pharmacol. Exp. Ther., 246:65-75.
13. Loscher, W., and Honack, D. (1990) The effect of interstimulation interval on the assessment of anticonvulsant drug potency in fully kindled rats. Epilepsy Res., 7:182-196.
14. Loscher, W., and Honack, D. (1991) Anticonvulsant and behavioral effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy. Comparison with MK-801 and carbamazepine. J. Pharmacol. Exp. Ther., 256:432-440.
15. Loscher, W., Honack, D., and Hashem, A. (1987) Anticonvulsant efficacy of clonazepam and the β-carboline ZK 93423 during chronic treatment in amygdala kindled rats. Eur. J. Pharmacol., 143:403-414.
16. Mattson, R.H., Cramer, J.A., Collins, J.F., Smith, D.B., Delgado-Escueta, A.V., Browne, T.R., Williamson, P.D., Treiman, D.M., McNamara, J.O., McCutchen, C.B., Homan, R.W., Crill, W.E., Lubozynski, M.F., Rosenthal, N.P., and Mayersdorf, A. (1985) Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. N. Engl. J. Med., 313:145-151.
17. McNamara, J.O., Bonhaus, D.W., and Shin, C. (1993) The kindling model of epilepsy. In: Epilepsy: Models, Mechanisms, and Concepts. P.A. Schwartzkorin, ed. Cambridge University Press, Cambridge, pp. 27-47.
18. McNamara, J.O., Russell, R.D., Rigsbee, L., and Bonhaus, D.W. (1988) Anticonvulsant and antiepileptogenic actions of MK-801 in the kindling and electroshock model. Neuropharmacology, 27:563-568.
19. Meldrum, B.S. (1992) Excitatory amino acids in epilepsy and potential novel therapies. Epilepsy Res., 12:189-196.
20. Meldrum, B.S. (1994) The role of glutamate in epilepsy and other CNS disorders. Neurology, 44(suppl. 8):S14-S23.
21. Minabe, Y., and Emori, K. (1992) Two types of neuroplasticities in the kindling phenomenon: Effects of chronic MK-801 and methamphetamine. Brain Res., 585:237-242.
22. Minabe, Y., Tanii, Y., and Kurachi, M. (1987) Acute effects of anticonvulsants on amygdaloid kindled seizures induced with low-frequency stimulations. Epilepsia, 28:222-228.
23. Minabe, Y., Emori, K., and Kurachi, M. (1991) Two types of neuroplasticities in the kindling phenomenon. Brain Res., 561:162-164.
24. Minabe, Y., Emori, K., and Uehara, T. (1993) Effect of long-stimulus intervals and scopolamine administration on hippocampal kindling. Brain Res., 600:322-326.
25. Mody, I., and Heinemann, U. (1987) NMDA receptors of dentate gyrus granule cells participate in synaptic transmission following kindling. Nature, 326:701-704.
26. Morimoto, K., and Goddard, G.V. (1986) Kindling-induced changes in EEG recorded during stimulation: Collapse of GABA-mediated inhibition and onset of rhythmic synchronous bursts. Exp. Neurol., 94:571-584.
27. Morimoto, K., Holmes, K.H., and Goddard, G.V. (1987) Kindling-induced changes in EEG recorded during stimulation from the site of stimulation. III. Direct pharmacological manipulations of the kindled amygdala. Exp. Neurol., 97:17-34.
28. Namba, T., Morimoto, K., Sato, K., Yamada, N., and Kuroda, S. (1994) Antiepileptogenic and anticonvulsant effects of NBQX, a selective AMPA receptor antagonist, in the rat kindling model of epilepsy. Brain Res., 638:36-44.
29. Namba, T., Morimoto, K., Sato, K., Yamada, N., and Otsuki, S. (1993) Antiepileptogenic action of 7-chlorokynurenic acid on amygdala kindling of rats. Pharmacol. Biochem. Behav., 46:275-281.
30. 1H-imidazol-1-yl)-7-nitro-2,3(1H,4H)- quinoxalinedione monohydrochloride (YM90K) and related compounds: Structure-activity relationships for the AMPA-type non-NMDA receptor. J. Med. Chem., 37:467-475.
31. Racine, R.J. (1972) Modification of seizure activity by electrical stimulation. I. Afterdischarge threshold. Electroenceph. Clin. Neurophysiol., 31:281-294.
32. Runfeldt, C., Wlaz, P., and Loscher, W. (1994) Anticonvulsant activity of antagonists and partial agonists for the NMDA receptor-associated glycine site in the kindling model of epilepsy. Brain Res., 653:125-130.
33. Sato, M., Racine, R.J., and McIntyre, D.C. (1990a) Kindling - Basic mechanisms and clinical validity. Electroencephalogr. Clin. Neurophysiol., 76:459-472.
34. Sato, K., Morimoto, K., Okamoto, M., Nakamura, Y., Otsuki, S., and Sato, M. (1990b) An analysis of anticonvulsant actions of GABA agonists (progabide and baclofen) in the kindling model of epilepsy. Epilepsy Res., 5:117-124.
35. Scheardown, M.J., Nielsen, E.O., Hansen, A.J., Jacobsen, P., and Honore, T. (1991) 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)-quinoxaline: Aneuroprotectant for cerebral ischemia. Science, 247: 571-574.
36. Silver, J.M., Shin, C., and McNamara, J.O. (1991) Antiepileptoogenic effects of conventional anticonvulsants in the kindling model of epilepsy. Ann. Neurol., 29:356-363.
37. Williamson, J.M., and Lothman, E.W. (1989) The effect of MK-801 on kindled seizures: Implications for use and limitations as an antiepileptic drug. Ann. Neurol., 26:85-90.
38. Wise, R.A., and Chinerman, J. (1974) Effects of diazepam and phenobarbital on electrically-induced amygdaloid seizures and seizure development. Exp. Neurol., 45:355-363.
39. Wong, E.H.F., Kemp, J.A., Priestley, T., Knight, A.R., Woodruff, G.N., and Iversen, L.L. (1986) The anticonvulsant MK-801 is a potent NMDA antagonist. Proc. Natl. Acad. Sci. USA, 83:7104-7108.